Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV Vaccines Immunogenicity and Safety”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04772534
What this trial is testing

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 314
Large-scale testing (Phase 3)Study completedNCT00481767
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.

Who this might be right for
Human Papillomavirus (HPV) Infection
GlaxoSmithKline 676
Early research (Phase 1)Study completedNCT03085381
What this trial is testing

A Phase I Study of Quadrivalent HPV Recombinant Vaccine

Who this might be right for
HPV Infections
Shanghai Bovax Biotechnology Co., Ltd. 90
Large-scale testing (Phase 3)Study completedNCT00380367
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 110
Large-scale testing (Phase 3)Active Not RecruitingNCT04199689
What this trial is testing

Efficacy Against Oral Persistent Infection, Immunogenicity and Safety of the 9-valent Human Papillomavirus Vaccine (9vHPV) in Men Aged 20-45 Years (V503-049)

Who this might be right for
Papillomavirus Infections
Merck Sharp & Dohme LLC 6,033
Post-approval studies (Phase 4)UnknownNCT05279248
What this trial is testing

The Immunogenicity and Safety of the Vaccination of Human Papillomavirus Vaccine and Measles-Mumps-Rubella Vaccine

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Measles+2 more
Zhejiang Provincial Center for Disease Control and Prevention 300
Testing effectiveness (Phase 2)WithdrawnNCT06142461
What this trial is testing

Safety and Immunogenicity of HPV Vaccine Administered Intradermally and Intramuscularly Via Needle-Free Injection System

Who this might be right for
Vaccine Reaction
PharmaJet, Inc.
Post-approval studies (Phase 4)UnknownNCT05415345
What this trial is testing

Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Hepatitis E Virus Infection
Xiamen Innovax Biotech Co., Ltd 480
Post-approval studies (Phase 4)Active Not RecruitingNCT07281677
What this trial is testing

Immunogenicity and Safety of Sequential 2vHPV-9vHPV Vaccination in Girls Aged 9-14 Years

Who this might be right for
HPV Infection
Zhejiang Provincial Center for Disease Control and Prevention 400
Large-scale testing (Phase 3)UnknownNCT06207175
What this trial is testing

Evaluate the Immunogenicity and Safety of Nonavalent Human Papillomavirus (HPV) Vaccine

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 1,260
Early research (Phase 1)UnknownNCT02888418
What this trial is testing

Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17

Who this might be right for
Cervical Cancer
Beijing Chaoyang District Centre for Disease Control and Prevention 135
Large-scale testing (Phase 3)Study completedNCT00090220
What this trial is testing

Evaluate the Safety, Immune Response, and Efficacy of Gardasil (V501, qHPV) in Mid-Adult Women (V501-019)

Who this might be right for
Healthy Adult Female ParticipantsPreventionPapillomavirus Infection+1 more
Merck Sharp & Dohme LLC 3,819
Large-scale testing (Phase 3)Study completedNCT02733068
What this trial is testing

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 12,000
Early research (Phase 1)Study completedNCT03929172
What this trial is testing

Safety, Tolerability and Immunogenicity of HPV-L2 Vaccine in Healthy Adult Male and Female Subjects

Who this might be right for
Papillomavirus Infections
2A Pharma AB 20
Large-scale testing (Phase 3)WithdrawnNCT02082639
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Post-approval studies (Phase 4)Study completedNCT01031069
What this trial is testing

Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 873
Large-scale testing (Phase 3)Study completedNCT00306241
What this trial is testing

Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Large-scale testing (Phase 3)Study completedNCT01755689
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine With or Without Co-administration of Cervarix and Boostrix in Female Adolescents and Young Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,300
Large-scale testing (Phase 3)Study completedNCT02567955
What this trial is testing

Immunogenicity and Safety of Gardasil-9 and Cervarix

Who this might be right for
HPV Vaccines Immunogenicity and Safety
Laval University 376
Large-scale testing (Phase 3)Study completedNCT00337428
What this trial is testing

Concomitant Use of Gardasil (V501, Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diptheria, Tetanus, Pertussis and Poliomyelitis Vaccine in Adolescents (V501-024)(COMPLETED)

Who this might be right for
Neoplasms, Glandular and EpithelialDiphtheriaTetanus+2 more
Merck Sharp & Dohme LLC 843
Next Page